Stimuli-responsive nanoparticles based on poly acrylic derivatives for tumor therapy

Int J Pharm. 2021 May 15:601:120506. doi: 10.1016/j.ijpharm.2021.120506. Epub 2021 Mar 31.

Abstract

Serve side effects caused by discriminate damage of chemotherapeutic drugs to normal cell and cancer cells remain a main obstacle in clinic. Hence, continuous efforts have been made to find ways to effectively enhance drug delivery and reduce side effects. Recent decades have witnessed impressive progresses in fighting against cancer, with improved understanding of tumor microenvironment and rapid development in nanoscale drug delivery system (DDS). Nanocarriers based on biocompatible materials provide possibilities to improve antitumor efficiency and minimize off-target effects. Among all kinds of biocompatible materials applied in DDS, polymeric acrylic derivatives such as poly(acrylamide), poly(acrylic acid), poly(N-isopropylacrylamide) present inherent biocompatibility and stimuli-responsivity, and relatively easy to be functionalized. Furthermore, nanocarrier based on polymeric acrylic derivatives have demonstrated high drug encapsulation, improved uptake efficiency, prolonged circulation time and satisfactory therapeutic outcome in tumor. In this review, we aim to discuss recent progress in design and development of stimulus-responsive poly acrylic polymer based nanocarriers for tumor targeting drug delivery.

Keywords: Acrylic acid; Drug delivery; Nanoparticles; Polymer; Stimuli-responsive.

Publication types

  • Review

MeSH terms

  • Biocompatible Materials / therapeutic use
  • Drug Carriers / therapeutic use
  • Drug Delivery Systems
  • Humans
  • Hydrogen-Ion Concentration
  • Nanoparticles*
  • Neoplasms* / drug therapy
  • Polymers / therapeutic use
  • Tumor Microenvironment

Substances

  • Biocompatible Materials
  • Drug Carriers
  • Polymers